Managing dentoalveolar surgical procedures in patients taking new oral anticoagulants

被引:18
|
作者
Sivolella, Stefano [1 ]
De Biagi, Marleen [1 ,2 ]
Brunello, Giulia [1 ]
Berengo, Mario [1 ]
Pengo, Vittorio [3 ]
机构
[1] Univ Padua, Dept Neurosci, Inst Clin Dent, Via Venezia 90, I-35129 Padua, Italy
[2] Univ Padua, Azienda Osped, Inst Clin Dent, Via Venezia 90, I-35129 Padua, Italy
[3] Padova Univ Hosp, Dept Cardiac Thorac & Vasc Sci, Via Giustiniani 2, I-35128 Padua, Italy
关键词
Dabigatran; Rivaroxaban; Apixaban; Oral anticoagulants; Oral surgery; DIRECT THROMBIN INHIBITOR; DABIGATRAN ETEXILATE; MANAGEMENT; RECOMMENDATIONS; RIVAROXABAN; ANTIDOTE; REVERSAL; WARFARIN; CARE;
D O I
10.1007/s10266-015-0195-4
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
The development of new orally administered anticoagulants, such as dabigatran, rivaroxaban, and apixaban, in the past few years has focused on avoiding some of the drawbacks associated with warfarin. This work aims to illustrate the main features of the most commonly used new oral anticoagulants, reviewing the current literature on the management of patients taking these drugs and needing oral and implant surgery, and discussing the currently proposed related guidelines.
引用
收藏
页码:258 / 263
页数:6
相关论文
共 50 条
  • [31] Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease
    Jain, Nishank
    Reilly, Robert F.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (02): : 278 - 287
  • [32] New oral anticoagulants in stroke and systemic embolism prevention in patients suffering from atrial fibrillation
    Sleszycka, Justyna
    Demkow, Marcin
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2011, 7 (03): : 242 - 247
  • [33] Stroke Prevention in Patients With Atrial Fibrillation: Focus on New Oral Anticoagulants
    Toth, Peter P.
    POSTGRADUATE MEDICINE, 2013, 125 (03) : 155 - 161
  • [34] Safety assessment of new oral anticoagulants
    Gasso Sanchez, Amalia
    Real Campana, Jose Manuel
    Franco Sorolla, Jose Miguel
    Povar Marco, Bienvenido Javier
    Abad Sazatornil, Maria Reyes
    MEDICINA CLINICA, 2019, 152 (12): : 482 - 487
  • [35] Bleeding complications in patients on new oral anticoagulants for venous thromboembolism in Kenya
    Obayo, Antonina
    Ngunga, Mzee
    Shah, Jasmit
    Sokwala, Ahmed
    Barasa, Anders
    CARDIOVASCULAR JOURNAL OF AFRICA, 2022, : 186 - 192
  • [36] Stroke Prevention in Atrial Fibrillation: Managing the Risks in Light of New Oral Anticoagulants
    John E. Strobeck
    Cardiovascular Drugs and Therapy, 2012, 26 : 331 - 338
  • [37] Management and outcome of gastrointestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs
    Pannach, Sven
    Goetze, Julia
    Marten, Sandra
    Schreier, Thomas
    Tittl, Luise
    Beyer-Westendorf, Jan
    JOURNAL OF GASTROENTEROLOGY, 2017, 52 (12) : 1211 - 1220
  • [38] Hemorrhagic stroke and new oral anticoagulants
    Derlon, V.
    Corbonnois, G.
    Martin, M.
    Toussaint-Hacquard, M.
    Audibert, G.
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2014, 33 (9-10): : 540 - 547
  • [39] New oral anticoagulants
    Lozano, F. S.
    Arcelus, J. I.
    Monreal, M.
    ANGIOLOGIA, 2010, 62 (01): : 26 - 32
  • [40] New oral anticoagulants for patients with nonvalvular atrial fibrillation
    Holden, Amber
    Azimi, Nassir
    Forest, Christopher P.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2015, 28 (11): : 28 - 34